Drug Shortage Report for PMS-SUMATRIPTAN
| Report ID | 253882 |
| Drug Identification Number | 02256428 |
| Brand name | PMS-SUMATRIPTAN |
| Common or Proper name | SUMATRIPTAN |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1x6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-31 |
| Estimated end date | 2025-05-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-04-01 | French | Compare |
| v1 | 2025-04-01 | English | Compare |
Showing 1 to 2 of 2